90 related articles for article (PubMed ID: 23268742)
1. Bioassay-guided isolation of proanthocyanidins with antiangiogenic activities.
Pesca MS; Dal Piaz F; Sanogo R; Vassallo A; Bruzual de Abreu M; Rapisarda A; Germanò MP; Certo G; De Falco S; De Tommasi N; Braca A
J Nat Prod; 2013 Jan; 76(1):29-35. PubMed ID: 23268742
[TBL] [Abstract][Full Text] [Related]
2. Grape seed proanthocyanidins inhibit angiogenesis via the downregulation of both vascular endothelial growth factor and angiopoietin signaling.
Huang S; Yang N; Liu Y; Hu L; Zhao J; Gao J; Li Y; Li C; Zhang X; Huang T
Nutr Res; 2012 Jul; 32(7):530-6. PubMed ID: 22901561
[TBL] [Abstract][Full Text] [Related]
3. The biflavonoid amentoflavone inhibits neovascularization preventing the activity of proangiogenic vascular endothelial growth factors.
Tarallo V; Lepore L; Marcellini M; Dal Piaz F; Tudisco L; Ponticelli S; Lund FW; Roepstorff P; Orlandi A; Pisano C; De Tommasi N; De Falco S
J Biol Chem; 2011 Jun; 286(22):19641-51. PubMed ID: 21471210
[TBL] [Abstract][Full Text] [Related]
4. Competitive ELISA-based screening of plant derivatives for the inhibition of VEGF family members interaction with vascular endothelial growth factor receptor 1.
Ponticelli S; Braca A; De Tommasi N; De Falco S
Planta Med; 2008 Mar; 74(4):401-6. PubMed ID: 18484531
[TBL] [Abstract][Full Text] [Related]
5. Bioassay-guided isolation of an alkaloid with antiangiogenic and antitumor activities from the extract of Fissistigma cavaleriei root.
Yang Z; Lu W; Ma X; Song D
Phytomedicine; 2012 Feb; 19(3-4):301-5. PubMed ID: 22240079
[TBL] [Abstract][Full Text] [Related]
6. Anti-angiogenic activity evaluation of secondary metabolites from Calycolpus moritzianus leaves.
Lepore L; Gualtieri MJ; Malafronte N; Cotugno R; Dal Piaz F; Ambrosio L; De Falco S; De Tommasi N
Nat Prod Commun; 2011 Jul; 6(7):943-6. PubMed ID: 21834229
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
8. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway.
Jung MH; Lee SH; Ahn EM; Lee YM
Carcinogenesis; 2009 Apr; 30(4):655-61. PubMed ID: 19228635
[TBL] [Abstract][Full Text] [Related]
9. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
Pradeep CR; Sunila ES; Kuttan G
Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
[TBL] [Abstract][Full Text] [Related]
10. Isolation and structural characterization of glycosides from an anti-angiogenic extract of Monnina obtusifolia H.B.K.
Lepore L; Malafronte N; Condero FB; Gualtieri MJ; Abdo S; Dal Piaz F; De Tommasi N
Fitoterapia; 2011 Mar; 82(2):178-83. PubMed ID: 20816726
[TBL] [Abstract][Full Text] [Related]
11. Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2.
Chung TW; Kim SJ; Choi HJ; Kim KJ; Kim MJ; Kim SH; Lee HJ; Ko JH; Lee YC; Suzuki A; Kim CH
Glycobiology; 2009 Mar; 19(3):229-39. PubMed ID: 18974200
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of tumor-induced angiogenesis and its mechanism by ardipusilloside I purified from Ardisia pusilla.
Wang R; Gu Y; Zhang WD; Yan XN; Jin L; Wang XJ
J Asian Nat Prod Res; 2012; 14(1):55-63. PubMed ID: 22263594
[TBL] [Abstract][Full Text] [Related]
13. Artesunate reduces chicken chorioallantoic membrane neovascularisation and exhibits antiangiogenic and apoptotic activity on human microvascular dermal endothelial cell.
Huan-huan C; Li-Li Y; Shang-Bin L
Cancer Lett; 2004 Aug; 211(2):163-73. PubMed ID: 15219940
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of angiogenesis by a 27 kDa lectin from perivitelline fluid of horseshoe crab embryos through upregulation of VEGF and its receptor.
Surekha KL; Waghchoude M; Ghaskadbi S
J Nat Prod; 2013 Jan; 76(1):117-20. PubMed ID: 23316979
[TBL] [Abstract][Full Text] [Related]
15. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
16. Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist.
Alessi P; Leali D; Camozzi M; Cantelmo A; Albini A; Presta M
Eur Cytokine Netw; 2009 Dec; 20(4):225-34. PubMed ID: 20167562
[TBL] [Abstract][Full Text] [Related]
17. Proanthocyanidins and a phloroglucinol derivative from Rumex acetosa L.
Bicker J; Petereit F; Hensel A
Fitoterapia; 2009 Dec; 80(8):483-95. PubMed ID: 19695312
[TBL] [Abstract][Full Text] [Related]
18. Assessing the in vivo efficacy of biologic antiangiogenic therapies.
Wilson PM; LaBonte MJ; Lenz HJ
Cancer Chemother Pharmacol; 2013 Jan; 71(1):1-12. PubMed ID: 23053262
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
Haspel HC; Scicli GM; McMahon G; Scicli AG
Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
[TBL] [Abstract][Full Text] [Related]
20. Artesunate inhibits angiogenesis and downregulates vascular endothelial growth factor expression in chronic myeloid leukemia K562 cells.
Zhou HJ; Wang WQ; Wu GD; Lee J; Li A
Vascul Pharmacol; 2007; 47(2-3):131-8. PubMed ID: 17581794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
